P/R= 1.21
P/CF=13.1
P/E= 4.8
CR= 4.05
Net Profit Margin= 25.05%
Yield= 3.52%
Source: T1
Builds machines that carry out automated manufacturing.
Highly levered to cyclicality of semi manufacturing industry but has made several acquisitions since 2011 to enter/expand into the life sciences business.
Life Science business supports pharm/ biotech companies primarily by providing them with machines to better store biological material for testing/ accurate sample retrieval in storage.
Revs from Life Sciences increased from 2% in 2011 to 10% in 2012.
EPS earnings beat last quarter with -.06 vs -.09 consensus. Analysts have them going to EPS of $.10 in Q2.
Thoughts? Considerations? Anybody cover them?
Eos consequatur totam ab quia eos cupiditate. Sequi vitae ab magnam porro vel iste vitae. Quo aut nisi quisquam aut nihil consequatur facere. Sit quam sit quia dolore. Molestiae aliquid voluptatum rem architecto natus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...